LifeScience PLUS

LifeScience PLUS

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

LifeScience PLUS is a private, commercial-stage company specializing in advanced hemostasis and wound healing products. Its core technology is a patented, plant-based etherified carboxymethyl cellulose (eCMC) matrix that rapidly controls bleeding and creates an optimal environment for healing. The company is actively marketing its flagship BloodSTOP iX product across surgical, emergency, and chronic care settings, with clinical evidence supporting expansion into new applications like neurosurgery. LifeScience PLUS operates in the large and growing global advanced wound care market.

Wound CareHemostasisSurgical Bleeding

Technology Platform

Patented, plant-based etherified carboxymethyl cellulose (eCMC) matrix that activates the intrinsic coagulation cascade for rapid hemostasis and forms a protective, water-soluble membrane to promote healing.

Opportunities

Large and growing global advanced wound care market driven by aging populations and chronic diseases.
Expansion into new high-value clinical applications like neurosurgery presents significant upside.
The plant-based, multifunctional nature of the product differentiates it from many existing alternatives.

Risk Factors

Faces intense competition from large, established medtech companies in the wound care space.
Commercial scaling and securing favorable reimbursement are significant challenges for a private company.
Market adoption requires changing clinician behavior, which can be slow.

Competitive Landscape

Competes in the advanced hemostat and wound dressing market against giants like Johnson & Johnson (Ethicon), Baxter, and 3M, as well as specialized firms like Hemostasis, LLC. Differentiation is based on its plant-based, multi-action (hemostasis + healing) platform and water-soluble removal.